These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 35653026)

  • 1. Identification of conserved regions from 230,163 SARS-CoV-2 genomes and their use in diagnostic PCR primer design.
    Jeong H; Lee S; Ko J; Ko M; Seo HW
    Genes Genomics; 2022 Aug; 44(8):899-912. PubMed ID: 35653026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How to choose the right real-time RT-PCR primer sets for the SARS-CoV-2 genome detection?
    Anantharajah A; Helaers R; Defour JP; Olive N; Kabera F; Croonen L; Deldime F; Vaerman JL; Barbée C; Bodéus M; Scohy A; Verroken A; Rodriguez-Villalobos H; Kabamba-Mukadi B
    J Virol Methods; 2021 Sep; 295():114197. PubMed ID: 34033854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In silico evaluation of the impact of Omicron variant of concern sublineage BA.4 and BA.5 on the sensitivity of RT-qPCR assays for SARS-CoV-2 detection using whole genome sequencing.
    Sharma D; Notarte KI; Fernandez RA; Lippi G; Gromiha MM; Henry BM
    J Med Virol; 2023 Jan; 95(1):e28241. PubMed ID: 36263448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deepening of In Silico Evaluation of SARS-CoV-2 Detection RT-qPCR Assays in the Context of New Variants.
    Gand M; Vanneste K; Thomas I; Van Gucht S; Capron A; Herman P; Roosens NHC; De Keersmaecker SCJ
    Genes (Basel); 2021 Apr; 12(4):. PubMed ID: 33924636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing oligonucleotide designs from early lab developed PCR diagnostic tests for SARS-CoV-2 using the PCR_strainer pipeline.
    Kuchinski KS; Jassem AN; Prystajecky NA
    J Clin Virol; 2020 Oct; 131():104581. PubMed ID: 32889496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PCR Primer Design for the Rapidly Evolving SARS-CoV-2 Genome.
    Qu W; Li J; Cai H; Zhao D
    Methods Mol Biol; 2022; 2392():185-197. PubMed ID: 34773624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Developing an Amplification Refractory Mutation System-Quantitative Reverse Transcription-PCR Assay for Rapid and Sensitive Screening of SARS-CoV-2 Variants of Concern.
    Xiong D; Zhang X; Shi M; Wang N; He P; Dong Z; Zhong J; Luo J; Wang Y; Yu J; Wei H
    Microbiol Spectr; 2022 Feb; 10(1):e0143821. PubMed ID: 34985323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid and Accurate Identification of SARS-CoV-2 Variants Using Real Time PCR Assays.
    Borillo GA; Kagan RM; Marlowe EM
    Front Cell Infect Microbiol; 2022; 12():894613. PubMed ID: 35619652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Analysis of Nucleotide Changes in RT-PCR Primer/Probe Binding Regions in SARS-CoV-2 Isolates Reported from Turkey].
    Demir AB; Bulgurcu A; Appak Ö; Sayıner AA
    Mikrobiyol Bul; 2021 Jul; 55(3):311-326. PubMed ID: 34416799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accuracy of Real-Time Polymerase Chain Reaction in COVID-19 Patients.
    Lawrence Panchali MJ; Oh HJ; Lee YM; Kim CM; Tariq M; Seo JW; Kim DY; Yun NR; Kim DM
    Microbiol Spectr; 2022 Feb; 10(1):e0059121. PubMed ID: 35170995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design and in silico validation of polymerase chain reaction primers to detect severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
    Davi MJP; Jeronimo SMB; Lima JPMS; Lanza DCF
    Sci Rep; 2021 Jun; 11(1):12565. PubMed ID: 34131209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular detection of SARS-CoV-2 strains and differentiation of Delta variant strains.
    Hamill V; Noll L; Lu N; Tsui WNT; Porter EP; Gray M; Sebhatu T; Goerl K; Brown S; Palinski R; Thomason S; Almes K; Retallick J; Bai J
    Transbound Emerg Dis; 2022 Sep; 69(5):2879-2889. PubMed ID: 34964565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimization and validation of RT-LAMP assay for diagnosis of SARS-CoV2 including the globally dominant Delta variant.
    Jamwal VL; Kumar N; Bhat R; Jamwal PS; Singh K; Dogra S; Kulkarni A; Bhadra B; Shukla MR; Saran S; Dasgupta S; Vishwakarma RA; Gandhi SG
    Virol J; 2021 Aug; 18(1):178. PubMed ID: 34461941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. End-point RT-PCR based on a conservation landscape for SARS-COV-2 detection.
    Cruz-Rangel A; Gómez-Romero L; Cisneros-Villanueva M; de Anda Jáuregui G; Luna-Pineda V; Cedro-Tanda A; Campos-Romero A; Mendoza-Vargas A; Reyes-Grajeda JP; Hidalgo-Miranda A; ; Herrera LA; Vadillo-Ortega F
    Sci Rep; 2022 Mar; 12(1):4759. PubMed ID: 35306521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of the potential impact of genomic variants in global SARS-CoV-2 genomes on molecular diagnostic assays.
    Jain A; Rophina M; Mahajan S; Krishnan BB; Sharma M; Mandal S; Fernandez T; Sultanji S; Jolly B; Mathew S; Sivasubbu S; Scaria V
    Int J Infect Dis; 2021 Jan; 102():460-462. PubMed ID: 33181329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SARS-CoV-2 Variants Identification; A Fast and Affordable Strategy Based on Partial S-Gene Targeted PCR Sequencing.
    Martínez-Murcia A; Garcia-Sirera A; Navarro A; Pérez L
    Viruses; 2022 Nov; 14(11):. PubMed ID: 36423197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of nsp1 gene as the target of SARS-CoV-2 real-time RT-PCR using nanopore whole-genome sequencing.
    Chan WM; Ip JD; Chu AW; Yip CC; Lo LS; Chan KH; Ng AC; Poon RW; To WK; Tsang OT; Leung WS; Kwan MY; Chua GT; Chung TW; Hung IF; Kok KH; Cheng VC; Chan JF; Yuen KY; To KK
    J Med Virol; 2020 Nov; 92(11):2725-2734. PubMed ID: 32501535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RT-qPCR Diagnostics: The "Drosten" SARS-CoV-2 Assay Paradigm.
    Bustin S; Kirvell S; Huggett JF; Nolan T
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of mutations in SARS-CoV-2 PCR primer regions.
    Mentes A; Papp K; Visontai D; Stéger J; ; Csabai I; Medgyes-Horváth A; Pipek OA
    Sci Rep; 2022 Nov; 12(1):18651. PubMed ID: 36333366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple assays in a real-time RT-PCR SARS-CoV-2 panel can mitigate the risk of loss of sensitivity by new genomic variants during the COVID-19 outbreak.
    Peñarrubia L; Ruiz M; Porco R; Rao SN; Juanola-Falgarona M; Manissero D; López-Fontanals M; Pareja J
    Int J Infect Dis; 2020 Aug; 97():225-229. PubMed ID: 32535302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.